Supportive Treatment of Chemotherapy-Induced Neutropenia with Biosimilar Filgrastim: the HEXAFIL Non-Interventional Study. 1. Juni 2011 Tesch, H., Indorf, M., Schaller-Kranz, T., 2011. EMCC / ESMO (Poster 280, Abstract 4025), 308. Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer. Stemmler, H.J., Digioia, D., Freier, W., Tessen, H.W., Gitsch, G., Jonat, W., Brugger, W., Kettner, E., Abenhardt, W., Tesch, H., Hurtz, H.J., Rösel, S., Brudler,… Weiterlesen Analysis of the non-interventional study with Filgrastim-Hexal®: safety profile and patient perception. Tesch, H., Indorf, M., Schmid, T., Rauh, J., Stoetzer, O., Schaller-Kranz, T., 2011 Onkologie 34 (suppl 6)(P867), 259. doi:10.1159/000333304 Abstract… Weiterlesen